In order to advance medical research in these important areas, it has been important to operate in an environment that accurately represents the BBB. As such, researchers have turned to animal subjects, something which comes with significant ethical and moral questions. The desire has been, therefore, to create some type of substitute for a living creature, but limits to current fabrication techniques had made such models impossible to produce. That is, until now. In an article recently published in the journal Small researchers detailed a breakthrough in high resolution 3D printing that has allowed them to “faithfully reproduc[e] the microcapillaries of the neurovascular system on a 1:1 scale.” As explained by Gianni Ciofani, Associate Professor at Polytechnic University of Torino and Principal Investigator of the Smart Bio-Interfaces group at the Italian Institute of Technology:
“The bio-hybrid BBB developed in our laboratories allows [one] to carry out high-throughput screening of different drugs/compounds/nanovectors, and to evaluate their ability to cross the BBB. Furthermore, our bio-hybrid platform allows [one] to rigorously study the BBB crossing by avoiding the use of animal models, thus overcoming the issues related to the scarce accessibility of the brain and limiting important ethical concerns.”

Confocal acquisition of the bio-hybrid BBB model (f-actin, ZO-1 and nuclei of bEnd3 cells have been stained in red, green and blue respectively). [Image: Gianni Ciofani, IIT]
“The novelty of our work mainly consists in the fabrication of a reliable platform to carry out high throughput quantitative investigations of drug delivery to the brain. The in vitro model provides a closed system where the different variables such as drug concentration, blood flow speed, pH, and temperature can be easily turned and monitored, thus providing precious and detailed information about the BBB crossing in real time and at cellular/subcellular levels.”

3D rendering of confocal acquisition of the bio-hybrid BBB model (f-actin, ZO-1 and nuclei of bEnd3 cells have been stained in red, green and blue respectively). [Image: Gianni Ciofani, IIT]
“We strongly believe that nanotechnology-based solutions such as nanocarriers and nanovectors for thernostic applications show enormous potential for the treatment of brain pathologies…In this context, the new generation of remotely triggered smart nanomaterials represents, in our opinion, the future solution for the treatment of brain diseases. The BBB model we developed represents a powerful testing tool to achieve these goals.”
What do you think of this news? Let us know your thoughts; join the discussion of this and other 3D printing topics at 3DPrintBoard.com or share your thoughts below.
[Source: Nanowerk]
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
Upload your 3D Models and get them printed quickly and efficiently.
You May Also Like
Spanish Researchers Use Meltio’s Metal 3D Printing to Create Titanium Implants
A group of Spanish researchers is rethinking how titanium implants are made, and they’re doing it with 3D printing. The team behind the ATILA Project has used Meltio’s metal additive...
3D Printing News Briefs, November 6, 2025: Filament Drying, Personalized Medicines, Cricket Arm Guard, & More
In today’s 3D Printing News Briefs, Thought3D has upgraded its filament drying system. Moving on to dental and medical news, LuxCreo received a strategic investment to help develop next-generation 3D...
3D Printing News Briefs, November 1, 2025: Hydraulics, Radiation Resistance, Sweat Analysis, & More
We’re starting with European business news in this weekend’s News Briefs, as ASTM International and CECIMO are collaborating to drive additive manufacturing in Europe, and Farsoon Europe has opened a...
A Textbook AM Use-Case: Materialise & Vocus Partner to 3D Print a Glider Muffler
Quick wins are nice, but slow wins usually mean more. Patience doesn’t always pay off in the additive manufacturing (AM) industry, though when it does, the rewards equal the wait....



























